Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months
Objectives. Bisphosphonates related osteonecrosis of the jaw (BRONJ) is a pathological condition characterized by bone exposure or latent infection in patients treated with the drug. The aim of the study is to monitor the BRONJ level of risk health in patients with cancer, according to a preventive...
Saved in:
Main Authors: | Scilla Sparabombe (Author), Lucia Vitali (Author), Alessandra Nori (Author), Ricarda Sara Berlin (Author), Marta Mazur (Author), Giovanna Orsini (Author), Angelo Putignano (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
by: Hiromitsu Kishimoto, et al.
Published: (2019) -
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
by: Petcu Eugen B, et al.
Published: (2012) -
Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
by: Thomas Ziebart, et al.
Published: (2016) -
Non-exposed variant of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with a plasmacytoma: A rare case report
by: Arvind Muthukrishnan, et al.
Published: (2015) -
Use of over-the-counter mouthwashes as an additional measure in individual oral prophylaxis on adults with plaque-induced gingivitis: a double-blind, parallel, randomized controlled trial
by: Flavia Vitiello, et al.
Published: (2024)